Biotechnology Stocks
254 biotechnology companies we track, ranked by market cap. Click any ticker for fundamentals, insider trading, and institutional ownership.
| Ticker | Company | Industry | Market Cap |
|---|---|---|---|
| ABBV | AbbVie Inc | — | $356.5B |
| AMGN | Amgen Inc | — | $179.0B |
| REGN | Regeneron Pharmaceuticals Inc | — | $74.9B |
| ALNY | Alnylam Pharmaceuticals Inc | — | $39.4B |
| BIIB | Biogen Inc | — | $28.6B |
| MRNA | Moderna Inc | — | $21.6B |
| EXAS | Exact Sciences Corp | — | $20.0B |
| INCY | Incyte Corp | — | $19.7B |
| ASND | Ascendis Pharma A/S | — | $14.9B |
| BBIO | BridgeBio Pharma Inc | — | $13.2B |
| IONS | Ionis Pharmaceuticals Inc | — | $12.5B |
| BMRN | BioMarin Pharmaceutical Inc | — | $10.4B |
| KYMR | Kymera Therapeutics Inc | — | $7.1B |
| MIRM | Mirum Pharmaceuticals Inc | — | $6.5B |
| CELC | Celcuity Inc | — | $6.3B |
| CNTA | Centessa Pharmaceuticals PLC | — | $6.1B |
| COGT | Cogent Biosciences Inc | — | $5.9B |
| LEGN | Legend Biotech Corp | — | $5.3B |
| APLS | Apellis Pharmaceuticals Inc | — | $5.3B |
| FOLD | Amicus Therapeutics Inc | — | $4.5B |
| TVTX | Travere Therapeutics Inc | — | $4.0B |
| ORKA | Oruka Therapeutics Inc | — | $3.9B |
| CPRX | Catalyst Pharmaceuticals Inc | — | $3.8B |
| VKTX | Viking Therapeutics Inc | — | $3.6B |
| BEAM | Beam Therapeutics Inc | — | $3.3B |
| TNGX | Tango Therapeutics Inc | — | $3.3B |
| DYN | Dyne Therapeutics, Inc | — | $2.9B |
| SLNO | Soleno Therapeutics Inc | — | $2.8B |
| CLDX | Celldex Therapeutics Inc | — | $2.7B |
| RARE | Ultragenyx Pharmaceutical Inc | — | $2.6B |
| KOD | Kodiak Sciences Inc | — | $2.5B |
| RLAY | Relay Therapeutics Inc | — | $2.4B |
| ETNB | 89bio Inc | — | $2.2B |
| TYRA | Tyra Biosciences Inc | — | $2.0B |
| AUPH | Aurinia Pharmaceuticals Inc | — | $2.0B |
| SION | Sionna Therapeutics Inc | — | $2.0B |
| INBX | Inhibrx Biosciences Inc | — | $2.0B |
| SNDX | Syndax Pharmaceuticals Inc | — | $1.9B |
| VRDN | Viridian Therapeutics Inc | — | $1.8B |
| CAPR | Capricor Therapeutics Inc | — | $1.8B |
| QURE | Uniqure NV | — | $1.7B |
| ARDX | Ardelyx Inc | — | $1.7B |
| NTLA | Intellia Therapeutics Inc | — | $1.7B |
| AGIO | Agios Pharmaceuticals Inc | — | $1.7B |
| AVBP | ArriVent BioPharma Inc | — | $1.4B |
| OLMA | Olema Pharmaceuticals Inc | — | $1.3B |
| ZBIO | Zenas Biopharma Inc | — | $1.3B |
| TRML | Tourmaline Bio Inc | — | $1.2B |
| CDNA | CareDx Inc | — | $1.1B |
| CVAC | CureVac NV | — | $1.0B |
| SANA | Sana Biotechnology Inc | — | $936.7M |
| ANNX | Annexon Inc | — | $924.7M |
| XNCR | Xencor Inc | — | $917.5M |
| SPRY | ARS Pharmaceuticals Inc | — | $867.9M |
| CTMX | CytomX Therapeutics Inc | — | $866.5M |
| JANX | Janux Therapeutics Inc | — | $862.3M |
| ABUS | Arbutus Biopharma Corp | — | $854.7M |
| KURA | Kura Oncology Inc | — | $836.1M |
| VOR | Vor Biopharma Inc | — | $775.2M |
| ALLO | Allogene Therapeutics Inc | — | $755.3M |
| SLDB | Solid Biosciences Inc | — | $715.3M |
| IRWD | Ironwood Pharmaceuticals Inc | — | $688.1M |
| CABA | Cabaletta Bio Inc | — | $632.6M |
| ALT | Altimmune Inc | — | $600.6M |
| KYTX | Kyverna Therapeutics Inc | — | $566.0M |
| PROK | Prokidney Corp | — | $561.6M |
| SAGE | SAGE Therapeutics Inc | — | $545.0M |
| RGNX | Regenxbio Inc | — | $544.6M |
| CLYM | Climb Bio Inc | — | $543.1M |
| MDXG | MiMedx Group Inc | — | $536.2M |
| ACHV | Achieve Life Sciences Inc | — | $534.9M |
| STTK | Shattuck Labs Inc | — | $517.7M |
| OCGN | Ocugen Inc | — | $511.2M |
| UPB | Upstream Bio Inc | — | $494.7M |
| KMDA | Kamada Ltd | — | $493.2M |
| EBS | Emergent BioSolutions Inc | — | $490.2M |
| OVID | Ovid Therapeutics Inc | — | $484.5M |
| SGMT | Sagimet Biosciences Inc | — | $471.7M |
| FBRX | Forte Biosciences Inc | — | $470.7M |
| XOMA | Xoma Royalty Corp | — | $469.6M |
| ITOS | iTeos Therapeutics Inc | — | $448.7M |
| CATX | Perspective Therapeutics Inc | — | $428.7M |
| IVVD | Invivyd Inc | — | $424.2M |
| BNTC | Benitec Biopharma Inc | — | $421.9M |
| IPSC | Century Therapeutics Inc | — | $412.3M |
| MYGN | Myriad Genetics Inc | — | $405.2M |
| XFOR | X4 Pharmaceuticals Inc | — | $381.9M |
| VIGL | Vigil Neuroscience Inc | — | $375.7M |
| NWBO | Northwest Biotherapeutics Inc | — | $374.4M |
| ZNTL | Zentalis Pharmaceuticals Inc | — | $368.8M |
| IRD | Opus Genetics Inc | — | $356.3M |
| LCTX | Lineage Cell Therapeutics Inc | — | $341.2M |
| IMRX | Immuneering Corp | — | $337.5M |
| ABEO | Abeona Therapeutics Inc | — | $336.6M |
| REPL | Replimune Group Inc | — | $336.1M |
| BCYC | Bicycle Therapeutics PLC | — | $335.3M |
| CMPX | Compass Therapeutics Inc. | — | $329.6M |
| GLSI | Greenwich Lifesciences Inc | — | $316.7M |
| AMRN | Amarin Corporation PLC | — | $311.3M |
| NVCT | Nuvectis Pharma Inc | — | $309.0M |
| PRLD | Prelude Therapeutics Inc | — | $306.2M |
| TARA | Protara Therapeutics Inc | — | $290.2M |
| CGEN | Compugen Ltd | — | $274.2M |
| TLSI | TriSalus Life Sciences Inc | — | $272.1M |
| IKT | Inhibikase Therapeutics Inc | — | $272.0M |
| CHRS | Coherus Oncology Inc | — | $269.9M |
| FENC | Fennec Pharmaceuticals Inc | — | $239.3M |
| KROS | Keros Therapeutics Inc | — | $238.8M |
| VYGR | Voyager Therapeutics Inc | — | $235.2M |
| ALEC | Alector Inc | — | $233.2M |
| TNYA | Tenaya Therapeutics Inc | — | $217.0M |
| TENX | Tenax Therapeutics Inc | — | $200.5M |
| UNCY | Unicycive Therapeutics Inc | — | $200.4M |
| DTIL | Precision BioSciences Inc | — | $198.4M |
| ANIK | Anika Therapeutics Inc | — | $196.5M |
| KPTI | Karyopharm Therapeutics Inc | — | $194.8M |
| MGNX | MacroGenics Inc | — | $190.7M |
| ELTX | Elicio Therapeutics Inc | — | $185.4M |
| ABOS | Acumen Pharmaceuticals Inc | — | $184.9M |
| ENLV | Enlivex Ltd | — | $182.8M |
| KRRO | Korro Bio Inc | — | $173.8M |
| GLLI | Alps Group Inc | — | $172.4M |
| BDTX | Black Diamond Therapeutics Inc | — | $171.3M |
| PRQR | ProQR Therapeutics NV | — | $166.5M |
| IMDX | Insight Molecular Diagnostics Inc | — | $161.2M |
| IMUX | Immunic Inc | — | $158.4M |
| OKUR | Onkure Therapeutics Inc | — | $157.9M |
| PLX | Protalix Biotherapeutics Inc | — | $156.3M |
| SPRO | Spero Therapeutics Inc | — | $148.2M |
| MRSN | Mersana Therapeutics Inc | — | $145.4M |
| EDSA | Edesa Biotech Inc | — | $144.8M |
| GNLX | Genelux Corp | — | $139.5M |
| GALT | Galectin Therapeutics Inc | — | $138.2M |
| EQ | Equillium Inc | — | $133.4M |
| CNTB | Connect Biopharma Holdings Ltd | — | $133.4M |
| VTVT | vTv Therapeutics Inc | — | $132.9M |
| ACOG | Alpha Cognition Inc | — | $132.8M |
| RCEL | AVITA Medical Inc | — | $126.5M |
| CRDF | Cardiff Oncology Inc | — | $112.1M |
| CBUS | Cibus Inc | — | $109.9M |
| CYPH | Cypherpunk Technologies Inc | — | $107.1M |
| KLRS | Kalaris Therapeutics Inc | — | $106.5M |
| MDXH | MDxHealth SA | — | $102.7M |
| ZSQR | Coeptis Therapeutics Holdings Inc | — | $102.1M |
| ANIX | Anixa Biosciences Inc | — | $100.6M |
| ENGN | enGene Therapeutics Inc | — | $100.5M |
| FRMM | Forum Markets, Inc | — | $93.6M |
| ATYR | aTyr Pharma Inc | — | $92.8M |
| CLNN | Clene Inc | — | $85.7M |
| PTHS | Pelthos Therapeutics Inc | — | $85.5M |
| CTOR | Citius Oncology Inc | — | $80.0M |
| ACTU | Actuate Therapeutics Inc | — | $78.2M |
| GANX | Gain Therapeutics Inc | — | $77.6M |
| FBIO | Fortress Biotech Inc | — | $77.0M |
| GOSS | Gossamer Bio Inc | — | $76.7M |
| ACRV | Acrivon Therapeutics Inc | — | $76.7M |
| RLYB | Rallybio Corp | — | $76.1M |
| TCRX | TScan Therapeutics Inc | — | $75.7M |
| XBIT | XBiotech Inc | — | $74.1M |
| KALA | KALA BIO Inc | — | $73.7M |
| ICCC | ImmuCell Corp | — | $72.8M |
| OSTX | OS Therapies Inc | — | $69.8M |
| PDSB | PDS Biotechnology Corp | — | $69.8M |
| MNOV | MediciNova Inc | — | $68.9M |
| IBIO | iBio Inc | — | $61.8M |
| BYSI | Beyondspring Inc | — | $61.3M |
| GRML | Greenland Mines Ltd | — | $55.8M |
| INKT | Mink Therapeutics Inc | — | $54.8M |
| MGX | Metagenomi Therapeutics Inc | — | $53.0M |
| SGMO | Sangamo Therapeutics Inc | — | $47.6M |
| LVTX | LAVA Therapeutics NV | — | $45.8M |
| ELUT | Elutia Inc | — | $44.7M |
| LITS | Lite Strategy Inc | — | $44.4M |
| PSTV | Plus Therapeutics Inc | — | $42.0M |
| RNXT | RenovoRx Inc | — | $38.9M |
| CRVO | CervoMed Inc | — | $36.6M |
| NXTC | NextCure Inc | — | $34.7M |
| PTN | Palatin Technologies Inc | — | $34.5M |
| RNTX | Rein Therapeutics Inc | — | $34.2M |
| NNVC | NanoViricides, Inc | — | $33.5M |
| BOLD | Boundless Bio Inc | — | $32.3M |
| BIOQ | Bioqual Inc | — | $31.5M |
| TVGN | Tevogen Bio Holdings Inc | — | $31.3M |
| NEUP | Neuphoria Therapeutics Inc | — | $28.6M |
| DYAI | Dyadic International Inc | — | $27.9M |
| ABVC | ABVC Biopharma Inc | — | $27.0M |
| OTLK | Outlook Therapeutics Inc | — | $26.7M |
| HRGN | Harvard Apparatus Regenerative Technology Inc | — | $26.4M |
| SER | Serina Therapeutics Inc | — | $26.1M |
| MRKR | Marker Therapeutics Inc | — | $24.3M |
| ELEV | Elevation Oncology LLC | — | $21.6M |
| GRDX | GridAI Technologies Corp | — | $21.2M |
| KTTA | Pasithea Therapeutics Corp | — | $19.8M |
| LGVN | Longeveron Inc | — | $19.7M |
| OSRH | OSR Holdings Inc | — | $18.9M |
| OTLC | Oncotelic Therapeutics Inc | — | $16.6M |
| TOVX | Theriva Biologics Inc | — | $16.2M |
| GRTX | Galera Therapeutics Inc | — | $16.1M |
| INAB | IN8bio Inc | — | $15.6M |
| CVM | CEL-SCI Corp | — | $14.4M |
| INTI | Inhibitor Therapeutics Inc | — | $14.3M |
| MDCX | Medicus Pharma Ltd | — | $14.0M |
| CMMB | Chemomab Therapeutics Ltd | — | $12.5M |
| PHIO | Phio Pharmaceuticals Corp | — | $12.4M |
| BCDA | BioCardia Inc | — | $12.1M |
| APRE | Aprea Therapeutics Inc | — | $12.1M |
| LNAI | Lunai Bioworks Inc | — | $12.0M |
| GTBP | GT Biopharma Inc | — | $11.8M |
| IMNN | Imunon Inc | — | $10.7M |
| BIAF | bioAffinity Technologies Inc | — | $9.1M |
| LIMN | Liminatus Pharma Inc | — | $9.1M |
| NCNA | NuCana PLC | — | $8.7M |
| BCAB | Bioatla Inc | — | $8.0M |
| ACXP | Acurx Pharmaceuticals Inc | — | $7.7M |
| BCLI | Brainstorm Cell Therapeutics Inc | — | $7.7M |
| AKTX | Akari Therapeutics PLC | — | $7.4M |
| EVGN | Evogene Ltd | — | $7.4M |
| APM | Aptorum Group Ltd | — | $6.8M |
| PHGE | BiomX Inc | — | $6.3M |
| TCRT | Alaunos Therapeutics Inc | — | $6.2M |
| APVO | Aptevo Therapeutics Inc | — | $5.9M |
| CLGN | Collplant Biotechnologies Ltd | — | $5.8M |
| MTVA | MetaVia Inc | — | $5.5M |
| CDIO | Cardio Diagnostics Holdings Inc | — | $5.4M |
| MBIO | Mustang Bio Inc | — | $5.3M |
| BRTX | BioRestorative Therapies Inc | — | $5.2M |
| SBFM | Sunshine Biopharma Inc | — | $5.2M |
| DRMA | Dermata Therapeutics Inc | — | $5.1M |
| ACUT | Accustem Sciences Inc | — | $4.9M |
| BGMS | Bio Green Med Solution Inc | — | $4.9M |
| AQB | AquaBounty Technologies Inc | — | $4.8M |
| GOVX | GeoVax Labs Inc | — | $4.8M |
| INDP | Indaptus Therapeutics Inc | — | $4.2M |
| MTNB | Matinas BioPharma Holdings Inc | — | $4.1M |
| GLMD | Galmed Pharmaceuticals Ltd | — | $4.0M |
| NYMXF | Nymox Pharmaceutical Corp | — | $3.3M |
| GRI | GRI Bio Inc | — | $3.2M |
| DCOY | Decoy Therapeutics Inc | — | $3.0M |
| AIM | AIM ImmunoTech Inc | — | $2.8M |
| CASI | CASI Pharmaceuticals Inc | — | $2.7M |
| PKTX | ProtoKinetix Inc | — | $2.1M |
| AXIM | Axim Biotechnologies Inc | — | $2.0M |
| BZYR | Burzynski Research Institute Inc | — | $1.4M |
| PTIX | Protagenic Therapeutics Inc | — | $1.4M |
| ISCO | International Stem Cell Corp | — | $1.4M |
| WINT | Windtree Therapeutics Inc | — | $731.5K |
| IOBT | IO Biotech Inc | — | $550.0K |
| NSTM | Novelstem International Corp | — | $493.3K |
| BPTH | Bio Path Holdings Inc | — | $468.0K |
| ONCO | Onconetix Inc | — | $263.3K |
| ADTX | Aditxt Inc | — | $107.5K |
| VINC | Vincerx Pharma Inc | — | $66.5K |
| SCPX | Scorpius Holdings Inc | — | $61.1K |
| LADX | LadRx Corp | — | $52.0K |